Aim
To characterise current insulin pump settings used in young patients with type 1 diabetes mellitus (T1DM) and their relationship to glycaemic and weight control.
Methods
This retrospective study included patients aged <18 years old with T1DM duration >1 year who were using the Medtronic pump device. Data from the insulin pumps including number of blood glucose (BG) tests per day, basal and bolus insulin parameters, carbohydrate ratio (CR) and insulin sensitivity factors (ISF) were averaged over 14 days for statistical analyses. Anthropometric data and recent HbA1c was also recorded.
Anzeige
Results
292 patients (144 males, 148 females) were included in the study. Participants had a median age (IQR) of 12.9 (10.0-15.1) years and pump duration of 2.8 (1.5-4.2) years. No significant differences in median HbA1c (IQR) were observed in preschool (n=14; HbA1c (8.0% (7.0 to 8.0%)), prepubertal (n=105; HbA1c (8.0% (8.0 to 9.0%)) and adolescent subjects (n=173; HbA1c (8.0% (8.0 to 9.0%)). Adolescents took significantly fewer boluses and BG tests per day compared to younger children (p<0.05). Age specific diurnal variation in basal insulin doses was noted. Additionally, stronger carbohydrate cover was used in real-life compared to the theoretical 500 rule while weaker corrections were used in real-life compared to the 100 rule. Predictors of lower HbA1c values included higher number of daily boluses, greater number of blood glucose testing per day, lower average CR/500 rule ratio and higher average ISF/100 rule ratio adjusted for age (R2 =0.22; p<0.01). Predictors of favourable weight (lower BMI-SDS) included lower total daily dose(units/day), lower percentage of basal to total daily insulin dose, weaker average CR and higher number of different CR adjusted for age (R2 = 0.33; p<0.05), although age was the strongest predictor (older age associated with lower BMI-SDS).
Conclusion
Insulin pump therapy requires continuous adjustments and glycaemic targets are achieved only by a minority. This study provided additional information on real life carbohydrate ratio and insulin sensitivity factor, which may be helpful in optimising pump therapy in the future.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.